Randomized phase III trial to evaluate omentum preserving gastrectomy for patients with resectable advanced gastric cancer: JCOG1711 (ROAD-GC). This is an ASCO Meeting Abstract from the 2020 ASCO ...
The Appraisal Committee considered evidence submitted by the manufacturer of bevacizumab and a review of this submission by the Evidence Review Group (ERG). The NO16966 study started as a phase 3, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback